Breaking News

Polyrizon Achieves Scaled Manufacturing Milestone for PL-14 Intranasal Allergy Spray

Completes a major manufacturing upscaling milestone for its proprietary nasal-spray product platform.

Author Image

By: Charlie Sternberg

Associate Editor

Polyrizon Ltd., a biotechnology company developing intranasal products based on its proprietary Capture & Contain (C&C) platform, has successfully transitioned from small-batch laboratory production to a larger-scale, controlled manufacturing run designed to validate key parameters of PL-14 formulation. PL-14 is Polyrizon’s innovative intranasal protective spray designed to create a fast-acting, moisturizing barrier inside the nasal cavity, helping to trap, isolate, and neutralize air...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters